Key facts
- It has raised $100K; the latest was Early Stage VC in Feb 2026.
- Notable investors include Antler, QAI Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Orbion
- ·The full record, as it builds
Funding rounds
No funding rounds for Orbion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orbion
Developer of an artificial intelligence-driven predictive platform designed to transform protein understanding, design and validation into a precise science. The company tackles protein research challenges through its predictive platform, enabling clients to save time and costs.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2025
- Employees
- 2
- Website
- orbion.life/
- Ownership
- Privately Held (backing)
Orbion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orbion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orbion in its N-PORT filings yet. We sweep new filings monthly.